LifePoint gets lease finance aid from FINOVA:
This article was originally published in Clinica
LifePoint, a rapid saliva testing company, has negotiated a $3 million line of credit in order to lease capital equipment without drawing on its cash reserves. Investment group FINOVA Capital finances the deal. LifePoint, based in Ontario, California, is developing therapeutic drug monitoring, alcohol and drugs-of-abuse testing.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.